Key clinical trials of decitabine/cedazuridine sponsored by Astex Pharmaceuticals, Inc

Drug(s)	Indication	Phase	Status	Location(s)	Identifier
Decitabine/cedazuridine, decitabine	MDS, CMML and AML	3	Recruiting	Multinational	ASTX727-02; NCT03306264
Decitabine/cedazuridine	MDS, CMML and AML	2	Enrolling by invitation	USA, Canada	ASTX727-06; NCT04093570
Decitabine/cedazuridine	MDS and CMML	1/2	Completed	USA, Canada	ASTX727-01; NCT02103478
Decitabine/cedazuridine	MDS	1/2	Recruiting	USA	ASTX727-03; NCT03502668

AML acute myeloid leukaemia, CMML chronic myelomonocytic leukaemia, MDS myelodysplastic syndrome